Satoki Nakamura

1.3k total citations
68 papers, 1.0k citations indexed

About

Satoki Nakamura is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Satoki Nakamura has authored 68 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 26 papers in Hematology and 14 papers in Organic Chemistry. Recurrent topics in Satoki Nakamura's work include Chronic Myeloid Leukemia Treatments (11 papers), Organophosphorus compounds synthesis (9 papers) and Acute Myeloid Leukemia Research (9 papers). Satoki Nakamura is often cited by papers focused on Chronic Myeloid Leukemia Treatments (11 papers), Organophosphorus compounds synthesis (9 papers) and Acute Myeloid Leukemia Research (9 papers). Satoki Nakamura collaborates with scholars based in Japan, Belgium and United Kingdom. Satoki Nakamura's co-authors include Kazunori Ohnishi, Kaori Shinjo, Kazuyuki Shigeno, Kensuke Naito, Akihiro Takeshita, Ryuzo Ohno, Naruhiko Sahara, Shinya Fujisawa, Miki Kobayashi and Haruhiko Sugimura and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Satoki Nakamura

68 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satoki Nakamura Japan	21	606	243	216	103	102	68	1.0k
Kaori Shinjo Japan	21	568 0.9×	577 2.4×	323 1.5×	47 0.5×	53 0.5×	51	1.1k
Jay Yang United States	18	810 1.3×	318 1.3×	281 1.3×	37 0.4×	156 1.5×	103	1.3k
Benedetta Peruzzi Italy	18	612 1.0×	122 0.5×	233 1.1×	58 0.6×	186 1.8×	38	1.2k
Silvia Rita Vitale Italy	16	429 0.7×	169 0.7×	251 1.2×	53 0.5×	333 3.3×	46	978
Masamichi Mori Japan	17	524 0.9×	249 1.0×	407 1.9×	64 0.6×	49 0.5×	41	1.1k
Prince George United States	6	945 1.6×	231 1.0×	142 0.7×	21 0.2×	77 0.8×	9	1.2k
Xiaofen Pan China	15	330 0.5×	141 0.6×	107 0.5×	102 1.0×	131 1.3×	35	706
Karoline Kollmann Austria	18	629 1.0×	305 1.3×	413 1.9×	23 0.2×	180 1.8×	31	1.2k
Phuong L. Doan United States	21	624 1.0×	564 2.3×	258 1.2×	108 1.0×	199 2.0×	57	1.4k
Yuning Liao China	25	1.1k 1.9×	70 0.3×	455 2.1×	90 0.9×	253 2.5×	58	1.6k

Countries citing papers authored by Satoki Nakamura

Since Specialization

Citations

This map shows the geographic impact of Satoki Nakamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoki Nakamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoki Nakamura more than expected).

Fields of papers citing papers by Satoki Nakamura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoki Nakamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoki Nakamura. The network helps show where Satoki Nakamura may publish in the future.

Co-authorship network of co-authors of Satoki Nakamura

This figure shows the co-authorship network connecting the top 25 collaborators of Satoki Nakamura. A scholar is included among the top collaborators of Satoki Nakamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoki Nakamura. Satoki Nakamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Higo, Shuichiro, Takumi Kondo, Takamaru Ishizu, et al.. (2020). Adeno-associated virus-mediated gene delivery promotes S-phase entry-independent precise targeted integration in cardiomyocytes. Scientific Reports. 10(1). 15348–15348. 20 indexed citations

Shinmura, Kazuya, Yuichi Kawanishi, Hisaki Igarashi, et al.. (2017). WDR62 overexpression is associated with a poor prognosis in patients with lung adenocarcinoma. Molecular Carcinogenesis. 56(8). 1984–1991. 18 indexed citations

Shinmura, Kazuya, Masanori Goto, Tao Hong, et al.. (2017). Mutation Spectrum Induced by 8‐Bromoguanine, a Base Damaged by Reactive Brominating Species, in Human Cells. Oxidative Medicine and Cellular Longevity. 2017(1). 7308501–7308501. 5 indexed citations

Shinmura, Kazuya, Hisaki Igarashi, Yuichi Kawanishi, et al.. (2014). CLCA2 as a Novel Immunohistochemical Marker for Differential Diagnosis of Squamous Cell Carcinoma from Adenocarcinoma of the Lung. Disease Markers. 2014. 1–11. 24 indexed citations

Shinmura, Kazuya, Masanori Goto, Tao Hong, et al.. (2014). Impaired 8-Hydroxyguanine Repair Activity of MUTYH Variant p.Arg109Trp Found in a Japanese Patient with Early-Onset Colorectal Cancer. Oxidative Medicine and Cellular Longevity. 2014. 1–12. 8 indexed citations

Natsume, Hiroko, Kazuya Shinmura, Tao Hong, et al.. (2012). The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer. Journal of Translational Medicine. 10(1). 97–97. 20 indexed citations

Nakamura, Satoki, Daisuke Yokota, Lin Tan, et al.. (2011). Down‐regulation of Thanatos‐associated protein 11 by BCR‐ABL promotes CML cell proliferation through c‐Myc expression. International Journal of Cancer. 130(5). 1046–1059. 22 indexed citations

Kitagawa, Kyoko, Yojiro Kotake, Yoshihiro Hiramatsu, et al.. (2010). GSK3 regulates the expressions of human and mouse c-Myb via different mechanisms. Cell Division. 5(1). 27–27. 14 indexed citations

Shimoyama, Kumiko, et al.. (2010). Activation of the Interferon Pathway in Peripheral Blood of Patients with Sjögren’s Syndrome. The Journal of Rheumatology. 38(2). 310–316. 46 indexed citations

10.

Ito, Satoru, Mitsuji Yamashita, Michio Fujie, et al.. (2009). Preparation And Characterization Of Phospholanes And Phospha Sugars As Novel Anti-Cancer Agents. Heterocyclic Communications. 15(1). 23–30. 8 indexed citations

11.

Takeshita, Akihiro, Kaori Shinjo, Takaaki Ono, et al.. (2009). CMC‐544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B‐cell chronic lymphocytic leukaemia and lymphoma. British Journal of Haematology. 146(1). 34–43. 47 indexed citations

12.

Nakamura, Satoki, Keiji Okinaka, Takaaki Ono, et al.. (2008). HOXA10 expression induced by Abl kinase inhibitors enhanced apoptosis through PI3K pathway in CML cells. Leukemia Research. 32(6). 962–971. 11 indexed citations

13.

Nakamura, Satoki, Keiji Okinaka, Takaaki Ono, et al.. (2008). KIS induces proliferation and the cell cycle progression through the phosphorylation of p27Kip1 in leukemia cells. Leukemia Research. 32(9). 1358–1365. 19 indexed citations

14.

Fujisawa, Shinya, Ryuzo Ohno, Kazuyuki Shigeno, et al.. (2006). Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide. Cancer Chemotherapy and Pharmacology. 59(4). 485–493. 49 indexed citations

15.

Sahara, Naruhiko, Akihiro Takeshita, Takaaki Ono, et al.. (2006). Role for interleukin-6 and insulin-like growth factor-I via PI3-K/Akt pathway in the proliferation of CD56− and CD56+ multiple myeloma cells. Experimental Hematology. 34(6). 736–744. 12 indexed citations

16.

Shigeno, Kazuyuki, Kensuke Naito, Naruhiko Sahara, et al.. (2005). Arsenic Trioxide Therapy in Relapsed or Refractory Japanese Patients with Acute Promyelocytic Leukemia: Updated Outcomes of the Phase II Study and Postremission Therapies. International Journal of Hematology. 82(3). 224–229. 80 indexed citations

17.

Sahara, Naruhiko, Akihiro Takeshita, Miki Kobayashi, et al.. (2004). Phenylarsine Oxide (PAO) More Intensely Induces Apoptosis in Acute Promyelocytic Leukemia and As₂O₃-Resistant APL Cell Lines than As₂O₃by Activating the Mitochondrial Pathway. Leukemia & lymphoma. 45(5). 987–995. 16 indexed citations

18.

Shigeno, Kazuyuki, Hitoshi Yoshida, Ling Pan, et al.. (2003). Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias. Cancer Letters. 213(1). 11–20. 32 indexed citations

19.

Zhang, Wen Jie, Kazunori Ohnishi, Hitoshi Yoshida, et al.. (2000). Spicamycin and KRN5500 Induce Apoptosis in Myeloid and Lymphoid Cell Lines with Down‐regulation of Bcl‐2 Expression and Modulation of Promyelocytic Leukemia Protein. Japanese Journal of Cancer Research. 91(6). 604–611. 7 indexed citations

20.

Nakamura, Satoki, Kazunori Ohnishi, Hitoshi Yoshida, et al.. (2000). Retrovirus-mediated gene transfer of granulocyte colony-stimulating factor receptor (G-CSFR) cDNA into MDS cells and induction of their differentiation by G-CSF. PubMed. 6(2). 61–70. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact